SEATTLE — Careful timing in measuring high-sensitivity C-reactive protein during the menstrual cycle can make all the difference in classifying young women's risk of cardiovascular disease, new data show.
From the annual meeting of the Society for Pediatric and Perinatal Epidemiologic Research
PREVIEW